A phase II study of single-agent nab-paclitaxel as second-line therapy in patients with metastatic urothelial carcinoma. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sridhar, SS
  • Canil, CM
  • Mukherjee, Som
  • Winquist, E
  • Elser, C
  • Eisen, A
  • Chung, A
  • Ko, Y

publication date

  • May 20, 2010